-
EP3823625
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3823625
| EP3823625 - CARDIO- AND RENOSAFE ANTIDIABETIC THERAPY [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 05.04.2023 Database last updated on 18.10.2024 | |
| Former | Request for examination was made Status updated on 23.04.2021 | ||
| Former | The international publication has been made Status updated on 25.01.2020 | ||
| Former | unknown Status updated on 23.07.2019 | Most recent event Tooltip | 02.08.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Boehringer Ingelheim International GmbH Binger Strasse 173 55216 Ingelheim am Rhein / DE | [2021/21] | Inventor(s) | 01 /
VON EYNATTEN, Maximilian Boehringer Ingelheim International GmbH Corporate Patents Binger Strasse 173 55216 Ingelheim am Rhein / DE | 02 /
JOHANSEN, Odd-Erik Boehringer Ingelheim International GmbH Corporate Patents Binger Strasse 173 55216 Ingelheim am Rhein / DE | [2021/21] | Representative(s) | Lutze, Oliver, et al Boehringer Ingelheim International GmbH Binger Straße 173 55216 Ingelheim am Rhein / DE | [N/P] |
| Former [2021/21] | Simon, Elke Anna Maria, et al Boehringer Ingelheim GmbH Binger Strasse 173 55216 Ingelheim am Rhein / DE | Application number, filing date | 19739615.3 | 16.07.2019 | [2021/21] | WO2019EP69126 | Priority number, date | EP20180184034 | 17.07.2018 Original published format: EP 18184034 | EP20180187272 | 03.08.2018 Original published format: EP 18187272 | EP20180197472 | 28.09.2018 Original published format: EP 18197472 | EP20180202843 | 26.10.2018 Original published format: EP 18202843 | EP20190177388 | 29.05.2019 Original published format: EP 19177388 | [2021/21] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020016230 | Date: | 23.01.2020 | Language: | EN | [2020/04] | Type: | A1 Application with search report | No.: | EP3823625 | Date: | 26.05.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.01.2020 takes the place of the publication of the European patent application. | [2021/21] | Search report(s) | International search report - published on: | EP | 23.01.2020 | Classification | IPC: | A61K31/522, A61P3/10 | [2021/21] | CPC: |
A61K31/522 (EP,KR,US);
A61K45/06 (KR);
A61K9/0053 (US);
A61P3/10 (EP,KR,US);
A61K2300/00 (KR)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/21] | Title | German: | KARDIO- UND RENOSICHERE ANTIDIABETISCHE THERAPIE | [2021/21] | English: | CARDIO- AND RENOSAFE ANTIDIABETIC THERAPY | [2021/21] | French: | THÉRAPIE ANTIDIABÉTIQUE CARDIOPROTECTRICE ET NÉPHROPROTECTRICE | [2021/21] | Entry into regional phase | 17.02.2021 | National basic fee paid | 17.02.2021 | Designation fee(s) paid | 17.02.2021 | Examination fee paid | Examination procedure | 15.02.2021 | Amendment by applicant (claims and/or description) | 17.02.2021 | Examination requested [2021/21] | 17.02.2021 | Date on which the examining division has become responsible | 04.04.2023 | Despatch of a communication from the examining division (Time limit: M06) | 08.11.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 05.01.2024 | Reply to a communication from the examining division | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 05.01.2024 | Request for further processing filed | 05.01.2024 | Full payment received (date of receipt of payment) Request granted | 15.01.2024 | Decision despatched | Fees paid | Renewal fee | 02.08.2021 | Renewal fee patent year 03 | 01.08.2022 | Renewal fee patent year 04 | 31.07.2023 | Renewal fee patent year 05 | 31.07.2024 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XI]US2013303462 (KLEIN THOMAS [DE], et al); | [XI]WO2014140284 (BOEHRINGER INGELHEIM INT [DE]); | by applicant | US5093330 | EP0564409 | WO9835958 | WO2004005281 | WO2006041976 | WO2007005572 | WO2007128761 |